Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Clinical and Translational Oncology
Published in: Clinical and Translational Oncology 6/2010

01-06-2010 | Research Articles

Cytoreductive surgery and perioperative intraperitoneal chemotherapy in patients with peritoneal carcinomatosis of colonic origin: outcomes after 7 years’ experience of a new centre for peritoneal surface malignancies

Authors: Pedro Bretcha-Boix, Jose Farré-Alegre, Manuel Sureda, Carlos Dussan, Juan José Pérez Ruixo, Antonio Brugarolas Masllorens

Published in: Clinical and Translational Oncology | Issue 6/2010

Login to get access
Metadata
Title
Cytoreductive surgery and perioperative intraperitoneal chemotherapy in patients with peritoneal carcinomatosis of colonic origin: outcomes after 7 years’ experience of a new centre for peritoneal surface malignancies
Authors
Pedro Bretcha-Boix
Jose Farré-Alegre
Manuel Sureda
Carlos Dussan
Juan José Pérez Ruixo
Antonio Brugarolas Masllorens
Publication date
01-06-2010
Publisher
Springer Milan
Published in
Clinical and Translational Oncology / Issue 6/2010
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-010-0531-7

Other articles of this Issue 6/2010

Clinical and Translational Oncology 6/2010 Go to the issue

Educational Series

Epigenetic therapy of lymphoma using histone deacetylase inhibitors

Case Reports

Cerebellar involvement in Hodgkin’s lymphoma: an atypical site of relapse

Special Article

Update on the surgical pathology standards on rectal cancer diagnosis, staging and quality assessment of surgery

Educational Series

Bypassing cellular senescence by genetic screening tools

Educational Series

Breast cancer stem cell hypothesis: clinical relevance (answering breast cancer clinical features)

Educational Series

Epithelial ovarian carcinoma: current evidences and future perspectives in the first-line setting
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits